179 related articles for article (PubMed ID: 37219693)
1. Phillygenin Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis: Suppression of Inflammation and Wnt/β-Catenin Signaling Pathway.
Wang C; Liu Y; Gong L; Xue X; Fu K; Ma C; Li Y
Inflammation; 2023 Aug; 46(4):1543-1560. PubMed ID: 37219693
[TBL] [Abstract][Full Text] [Related]
2. Phillygenin inhibits LPS-induced activation and inflammation of LX2 cells by TLR4/MyD88/NF-κB signaling pathway.
Hu N; Wang C; Dai X; Zhou M; Gong L; Yu L; Peng C; Li Y
J Ethnopharmacol; 2020 Feb; 248():112361. PubMed ID: 31683033
[TBL] [Abstract][Full Text] [Related]
3. Hepatoprotective effect of phillygenin on carbon tetrachloride-induced liver fibrosis and its effects on short chain fatty acid and bile acid metabolism.
Wang C; Ma C; Fu K; Liu Y; Gong L; Peng C; Li Y
J Ethnopharmacol; 2022 Oct; 296():115478. PubMed ID: 35716920
[TBL] [Abstract][Full Text] [Related]
4. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
[TBL] [Abstract][Full Text] [Related]
5. DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl
Liu QQ; Chen J; Ma T; Huang W; Lu CH
Sci Rep; 2024 Apr; 14(1):9425. PubMed ID: 38658618
[TBL] [Abstract][Full Text] [Related]
6. Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1.
Zhang C; Liu XQ; Sun HN; Meng XM; Bao YW; Zhang HP; Pan FM; Zhang C
Int Immunopharmacol; 2018 Oct; 63():183-190. PubMed ID: 30098497
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of annexin A1/N-formylpeptide receptor regulation of macrophage function to inhibit hepatic stellate cell activation through Wnt/β-catenin pathway.
Fan JH; Luo N; Liu GF; Xu XF; Li SQ; Lv XP
World J Gastroenterol; 2023 Jun; 29(22):3422-3439. PubMed ID: 37389234
[TBL] [Abstract][Full Text] [Related]
8. Gandouling inhibits hepatic fibrosis in Wilson's disease through Wnt-1/β-catenin signaling pathway.
Cheng C; Wang Q; Huang Y; Xue Q; Wang Y; Wu P; Liao F; Miao C
J Ethnopharmacol; 2023 Jul; 311():116445. PubMed ID: 37015279
[TBL] [Abstract][Full Text] [Related]
9. Phillygenin inhibited M1 macrophage polarization and reduced hepatic stellate cell activation by inhibiting macrophage exosomal miR-125b-5p.
Ma C; Wang C; Zhang Y; Li Y; Fu K; Gong L; Zhou H; Li Y
Biomed Pharmacother; 2023 Mar; 159():114264. PubMed ID: 36652738
[TBL] [Abstract][Full Text] [Related]
10. Phillygenin Inhibits TGF-β1-induced Hepatic Stellate Cell Activation and Inflammation: Regulation of the Bax/Bcl-2 and Wnt/β-catenin Pathways.
Wang C; Zhang S; Li Y; Gong L; Yao C; Fu K; Li Y
Inflammation; 2024 Feb; ():. PubMed ID: 38393550
[TBL] [Abstract][Full Text] [Related]
11. Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt/β-catenin signaling pathway in mice.
Liu QW; Ying YM; Zhou JX; Zhang WJ; Liu ZX; Jia BB; Gu HC; Zhao CY; Guan XH; Deng KY; Xin HB
Stem Cell Res Ther; 2022 Jun; 13(1):224. PubMed ID: 35659360
[TBL] [Abstract][Full Text] [Related]
12. Esculin inhibits hepatic stellate cell activation and CCl
Xu S; Chen Y; Miao J; Li Y; Liu J; Zhang J; Liang J; Chen S; Hou S
Phytomedicine; 2024 Jun; 128():155465. PubMed ID: 38471319
[TBL] [Abstract][Full Text] [Related]
13. Fisetin alleviates thioacetamide-induced hepatic fibrosis in rats by inhibiting Wnt/β-catenin signaling pathway.
El-Fadaly AA; Afifi NA; El-Eraky W; Salama A; Abdelhameed MF; El-Rahman SSA; Ramadan A
Immunopharmacol Immunotoxicol; 2022 Jun; 44(3):355-366. PubMed ID: 35255766
[TBL] [Abstract][Full Text] [Related]
14. Kaempferol attenuates carbon tetrachloride (CCl
Cao R; Cao C; Hu X; Du K; Zhang J; Li M; Li B; Lin H; Zhang A; Li Y; Wu L; Huang Y
Phytomedicine; 2023 Dec; 121():155125. PubMed ID: 37820466
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
[TBL] [Abstract][Full Text] [Related]
16. Carthami flos extract against carbon tetrachloride-induced liver fibrosis via alleviating angiogenesis in mice.
Xue X; Zhao X; Wang J; Wang C; Ma C; Zhang Y; Li Y; Peng C
Phytomedicine; 2023 Jan; 108():154517. PubMed ID: 36332390
[TBL] [Abstract][Full Text] [Related]
17. Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a.
Yu F; Fan X; Chen B; Dong P; Zheng J
Cell Physiol Biochem; 2016; 39(6):2409-2420. PubMed ID: 27832641
[TBL] [Abstract][Full Text] [Related]
18. Ligustroflavone ameliorates CCl
Kang R; Tian W; Cao W; Sun Y; Zhang HN; Feng YD; Li C; Li ZZ; Li XQ
Chin J Nat Med; 2021 Mar; 19(3):170-180. PubMed ID: 33781450
[TBL] [Abstract][Full Text] [Related]
19. Pigment epithelium-derived factor 34-mer peptide prevents liver fibrosis and hepatic stellate cell activation through down-regulation of the PDGF receptor.
Tsai TH; Shih SC; Ho TC; Ma HI; Liu MY; Chen SL; Tsao YP
PLoS One; 2014; 9(4):e95443. PubMed ID: 24763086
[TBL] [Abstract][Full Text] [Related]
20. Curcumin raises lipid content by Wnt pathway in hepatic stellate cell.
Zhang F; Lu C; Xu W; Shao J; Wu L; Lu Y; Zheng S
J Surg Res; 2016 Feb; 200(2):460-6. PubMed ID: 26414021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
